NextPlat Corp. (NASDAQ: NXPL, NXPLW) has announced preliminary expectations for sequential improvement in key financial and operational metrics for the fourth quarter ended December 31, 2025, compared to the third quarter. The anticipated progress stems from the company's strategic business refocusing initiatives and an increased contribution from higher-margin revenue streams.
The company expects its fourth-quarter 340B revenue to rise more than 90% sequentially. Total prescription volume is projected to increase by approximately 7%. Consolidated gross margin is expected to remain stable, with a significant margin expansion of 20% to 25% projected for the first quarter of 2026 as higher-margin contracted services continue to grow.
Management also cited anticipated reductions in annual operating expenses through structural cost initiatives. The company reported solid liquidity with approximately $13 million in cash, $15 million in working capital, and zero unsecured debt as of year-end. Continued momentum into early 2026 supports expectations for meaningful reductions in operating losses by the end of the second quarter.
NextPlat Corp. is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the company assists businesses in selling goods online, domestically, and internationally. NextPlat currently operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide, as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care.
The company expects to file its Form 10-K on or before March 31, 2026, and will host an earnings conference call. The latest news and updates relating to NXPL are available in the company's newsroom at https://ibn.fm/NXPL. To view the full press release, visit https://ibn.fm/EhdM5.
